Clinicians/NNS are/VBP expected/VBN to/TO have/VB up/RB -/HYPH to/TO -/HYPH date/NN and/CC broad/JJ knowledge/NN of/IN disease/NN treatment/NN options/NNS for/IN a/DT patient/NN ./.
Online/JJ health/NN knowledge/NN resources/NNS contain/VBP a/DT wealth/NN of/IN information/NN ./.
However/RB ,/, because/IN of/IN the/DT time/NN investment/NN needed/VBN to/TO disseminate/VB and/CC rank/VB pertinent/JJ information/NN ,/, there/EX is/VBZ a/DT need/NN to/TO summarize/VB the/DT information/NN in/IN a/DT more/JJR concise/JJ format/NN ./.
Our/PRP$ aim/NN of/IN the/DT study/NN is/VBZ to/TO provide/VB clinicians/NNS with/IN a/DT concise/JJ overview/NN of/IN popular/JJ treatments/NNS for/IN a/DT given/VBN disease/NN using/VBG information/NN automatically/RB computed/VBN from/IN Medline/NNP abstracts/NNS ./.
We/PRP analyzed/VBD the/DT treatments/NNS of/IN two/CD disorders/NNS -/HYPH Atrial/JJ Fibrillation/NN and/CC Congestive/JJ Heart/NN Failure/NN ./.
We/PRP calculated/VBD the/DT precision/NN ,/, recall/NN ,/, and/CC f/NN -/HYPH scores/NNS of/IN our/PRP$ two/CD ranking/VBG methods/NNS to/TO measure/VB the/DT accuracy/NN of/IN the/DT results/NNS ./.
For/IN Atrial/NNP Fibrillation/NNP disorder/NN ,/, maximum/JJ f/NN -/HYPH score/NN for/IN the/DT New/NNP Treatments/NNPS weighing/VBG method/NN is/VBZ 0.611/CD ,/, which/WDT occurs/VBZ at/IN 60/CD treatments/NNS ./.
For/IN Congestive/JJ Heart/NN Failure/NN disorder/NN ,/, maximum/JJ f/NN -/HYPH score/NN for/IN the/DT New/NNP Treatments/NNPS weighing/VBG method/NN is/VBZ 0.503/CD ,/, which/WDT occurs/VBZ at/IN 80/CD treatments/NNS ./.
